Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial

Publication date: June 2020Source: The Lancet Haematology, Volume 7, Issue 6Author(s): Aurelio Maggio, Antonis Kattamis, Mariagrazia Felisi, Giorgio Reggiardo, Amal El-Beshlawy, Mohamed Bejaoui, Laila Sherief, Soteroula Christou, Carlo Cosmi, Oscar Della Pasqua, Giovanni Carlo Del Vecchio, Aldo Filosa, Liana Cuccia, Hoda Hassab, Manika Kreka, Raffaella Origa, Maria Caterina Putti, Michael Spino, Paul Telfer, Bianca Tempesta

Source: The Lancet Haematology - May 27, 2020 Category: Hematology Source Type: research